[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1688138,2006,A1Locationinpatent:Page/Pagecolumn91
1172759-99-7
194017-69-1
51362-30-2
1016778-72-5
1545165-14-7
1375301-92-0 | 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-quinazoline | AA0013FT | MFCD11521590
13788-84-6 | 3-Methyl-4-phenyl-1h-pyrazole | AA0013XQ | MFCD00051752
1331777-74-2 | Cis-4-amino-1-Boc-3-hydroxypiperidine | AA0014AG | MFCD20922915
133343-34-7 | L-Cysteine, N-acetyl-S-[(3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxo-D-prolyl]- | AA0014N2 | MFCD01076525
1214363-66-2 | [3,4'-Bipyridine]-6-carboxylic acid | AA0014TZ | MFCD15476033
12152-94-2 | Ferroceneboronic acid | AA00152E | MFCD00059074
121579-86-0 | tert-Butyl 4-(chloromethyl)benzoate | AA001593 | MFCD15142807
1217474-04-8 | Methyl N-BOC-(2R,4R)-4-Aminopyrrolidine-2-carboxylate HCl | AA0015NB | MFCD11042656
1217805-48-5 | (R)-1-(tert-Butoxycarbonyl)-2-phenethylpyrrolidine-2-carboxylic acid | AA0015W7 | MFCD06659173
1218790-27-2 | 1-BOC-6-Bromoindole-3-boronic acid, pinacol ester | AA001668 | MFCD15143608